The Pediatric Research in Oncology Xenografting Consortium (PROXC) brings together members from institutions across the US to accelerate progress in finding effective therapies against pediatric cancer.

Principal Investigators

Filemon Dela Cruz, MD
Memorial Sloan Kettering Cancer Center/MSK Kids, New York, NY

Andrew Kung, MD, PhD
Memorial Sloan Kettering Cancer Center/MSK Kids, New York, NY

Ryan Roberts, MD, PhD
Nationwide Children’s Hospital and James Comprehensive Cancer Center at The Ohio State University, Columbus, OH

Brian Crompton, MD
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA

Elizabeth Stewart, MD
St. Jude Children’s Research Hospital, Memphis, TN

Nino Rainusso, MD
Texas Children’s Hospital/ Baylor College of Medicine, Houston, TX

Alejandro Sweet-Cordero, MD
University of California San Francisco, San Francisco, CA

Administrative

Project Manager

Raven Rose
Memorial Sloan Kettering Cancer Center, New York, NY

Data Manager

Xinyi Wang
Memorial Sloan Kettering Cancer Center, New York, NY

PDX Managers

Daoqi You
Memorial Sloan Kettering Cancer Center, New York, NY

Leanne Sayles
University of California San Francisco, San Francisco, CA

Clinical Research Compliance and Operations

Director

Mary Warren
Memorial Sloan Kettering Cancer Center, New York, NY

Program Manager

Janelle Walkley
Memorial Sloan Kettering Cancer Center, New York, NY